To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject Treated with the Low-Dose of BB-301 in the Phase 1b/2a ...

Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset——Joint poster with Bachem demonstrates ...

As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...

With the help of an expert, we explore the role this essential nutrient plays in the body and when and how it should be taken ...

Researchers from VIB and VUB now provide an interactive tool, based on a single-cell RNA-sequencing (scRNA-seq) atlas of the ...

Mithrl, an AI-powered platform revolutionizing scientific research, today announced a $4 million seed round to evolve the research and development process for scientific innovation globally. The round ...

Gene mutations have consequences both good and bad—from resistance to conditions like diabetes to susceptibility to certain ...

Zymo’s Quick DNA/RNA Viral MagBead Kit was automated using Analytik Jena’s Cybio FeliX pipetting robot. The CyBio FeliX ...

Shares of Avidity Biosciences RNA rose more than 12% on Wednesday after the company announced that it is expanding its ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...